Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Northern Dynasty Minerals, Splunk, Minerva Neurosciences, and Covia Holdings and Encourages Investors to Contact the Firm
January 13, 2021 17:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
ROSEN, A LEADING AND LONGSTANDING FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
January 08, 2021 17:08 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Northern Dynasty Minerals, Splunk, Minerva Neurosciences, and Covia Holdings and Encourages Investors to Contact the Firm
January 06, 2021 18:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
ROSEN, A HIGHLY RESPECTED FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
December 31, 2020 16:28 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 31, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Splunk, Minerva Neurosciences, Covia Holdings, and Semiconductor Manufacturing International Corporations and Encourages Investors to Contact the Firm
December 29, 2020 18:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinterest, Northern Dynasty Minerals, Splunk, and Minerva Neurosciences and Encourages Investors to Contact the Firm
December 22, 2020 19:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinterest, Northern Dynasty Minerals, Splunk, and Minerva Neurosciences and Encourages Investors to Contact the Firm
December 16, 2020 20:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinterest, Northern Dynasty Minerals, Splunk, and Minerva Neurosciences Encourages Investors to Contact the Firm
December 09, 2020 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Minerva Neurosciences Announces Outcome of Type C Meeting with FDA and Next Steps in the Development of Roluperidone
December 01, 2020 08:00 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Minerva Neurosciences to Present at Jefferies Virtual London Healthcare Conference
November 09, 2020 08:30 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...